Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Telecoms

Brazil breezing through macro headwinds

Over the past few weeks and months, the country has seen positive headlines for large deals, venture fundraising and corporate innovation initiatives


Sep 13, 2017
Sep 12, 2017

Analysis: NeoTract to be acquired for $1.1bn

Medical device producer NeoTract has agreed to be acquired by Teleflex for $1.1bn, giving an exit to Johnson & Johnson, a notable deal in a field where corporate commitments have been on the rise.

Sep 8, 2017

Metawave makes a splash with $7m seed round

Spun out from Xerox subsidiary Parc last month, Metawave has now raised $7m in a seed round backed by several venture capital firms.

Sep 6, 2017

Editorial: Expedia CEO's move to Uber follows venture successes

Following on from successes, such as eLong in China, and Expedia's former CEO Dara has a storied track record in using tools to keep its global edge.

Aug 28, 2017

Smarsh captures Cognia in acquisition deal

The phone-based audio archiving software provider has been acquired for an undisclosed amount, allowing Swisscom Ventures and Vodafone Ventures to exit.

Aug 21, 2017

Iconectiv plugs into $200m

Francisco Partners has purchased a 16.7% stake in Iconectiv, a subsidiary of Ericsson that has developed technology to interconnect telecom networks.

Aug 14, 2017

Big Deal: SoftBank Vision Fund goes big

Vision Fund's $2.5bn investment in Flipkart last week, together with its huge bets on Fanatics and Roivant, could indicate where it plans to invest in the longer term.

Aug 14, 2017

Editorial: Sports venturing offers the brave a way to swim in money

It is, as these deals in the past week show, a remarkable time in sports and content as the change in distribution routes also affects the $40bn advertising industry.

Aug 13, 2017

SoftBank allows $7.5m to go to Altaeros

Altaeros, the developer of an aerial broadband provision system, has raised $7.5m from SoftBank, the investor that supplied $7m for it in 2014.

Aug 11, 2017

Big Deal: Bristol-Myers Squibb tunes into IFM

The pharmaceutical company's acquisition of Novartis-backed IFM Therapeutics, consisting of $300m upfront and up to $2bn in milestone payments, is its fourth purchase of a CVC-backed company in under four years.

Aug 7, 2017
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here